A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment-Reference-Cited by-同舟云学术

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment

Published:2017-11-27 Issue:3 Volume:7 Page:e1398876
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Cauwels Anje¹,Van Lint Sandra¹,Garcin Geneviève²,Bultinck Jennyfer¹³,Paul Franciane²,Gerlo Sarah¹,Van der Heyden José¹,Bordat Yann²,Catteeuw Dominiek¹,De Cauwer Lode¹⁴^ORCID,Rogge Elke¹,Verhee Annick¹,Uzé Gilles²,Tavernier Jan¹

Affiliation:

1. Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium

2. University Montpellier, Place Eugène Bataillon, Montpellier, France

3. Present address: Oxyrane, Zwijnaarde-Gent, Belgium

4. Present address: Argenx BVBA, Zwijnaarde-Gent, Belgium

Funder

FWO

Advanced ERC

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1398876